Mostrar el registro sencillo del ítem
dc.contributor.author | Ambrosioni, Juan | |
dc.contributor.author | Coiras, Mayte | |
dc.contributor.author | Alcamí, José | |
dc.contributor.author | Miró, José M | |
dc.date.accessioned | 2019-02-12T14:54:10Z | |
dc.date.available | 2019-02-12T14:54:10Z | |
dc.date.issued | 2017 | |
dc.identifier.citation | Expert Rev Anti Infect Ther. 2017 May;15(5):421-423. | es_ES |
dc.identifier.issn | 1478-7210 | es_ES |
dc.identifier.uri | http://hdl.handle.net/20.500.12105/7170 | |
dc.description.sponsorship | This work was supported by the Spanish Ministry of Economy and Competitiveness (SAF2013-44677-R, SAF2016-78480-R); the Instituto de Salud Carlos III (ISCIII-FIS PI16CIII/00034); and the Spanish AIDS Research Network RD16CIII/0002/0001-ISCIII-FEDER. JAM developed this work in the frame of a ‘Juan de la Cierva 2012’ post-doctoral program, Ministerio de Competitividad, Spain. JMM received a personal intensification research grant #INT15/00168 during 2016 from Instituto de Salud Carlos III, Madrid, Spain. | es_ES |
dc.language.iso | eng | es_ES |
dc.publisher | Taylor & Francis | es_ES |
dc.type.hasVersion | VoR | es_ES |
dc.rights.uri | http://creativecommons.org/licenses/by-nc-sa/4.0/ | * |
dc.subject | HIV | es_ES |
dc.subject | TKI | es_ES |
dc.subject | Tyrosine kinase inhibitors | es_ES |
dc.subject | Acute/recent infection | es_ES |
dc.subject | Dasatinib | es_ES |
dc.subject | Primary infection | es_ES |
dc.subject | Viral reservoirs | es_ES |
dc.subject.mesh | Anti-HIV Agents | es_ES |
dc.subject.mesh | Antiretroviral Therapy, Highly Active | es_ES |
dc.subject.mesh | CD4-Positive T-Lymphocytes | es_ES |
dc.subject.mesh | Dasatinib | es_ES |
dc.subject.mesh | Gene Expression Regulation | es_ES |
dc.subject.mesh | HIV Infections | es_ES |
dc.subject.mesh | HIV-1 | es_ES |
dc.subject.mesh | Humans | es_ES |
dc.subject.mesh | Lymphocyte Activation | es_ES |
dc.subject.mesh | Phosphorylation | es_ES |
dc.subject.mesh | Protein Kinase Inhibitors | es_ES |
dc.subject.mesh | Protein-Tyrosine Kinases | es_ES |
dc.subject.mesh | SAM Domain and HD Domain-Containing Protein 1 | es_ES |
dc.subject.mesh | Time Factors | es_ES |
dc.title | Potential role of tyrosine kinase inhibitors during primary HIV-1 infection | es_ES |
dc.type | journal article | es_ES |
dc.rights.license | Atribución-NoComercial-CompartirIgual 4.0 Internacional | * |
dc.identifier.pubmedID | 28322065 | es_ES |
dc.format.volume | 15 | es_ES |
dc.format.number | 5 | es_ES |
dc.format.page | 421-423 | es_ES |
dc.identifier.doi | 10.1080/14787210.2017.1308823 | es_ES |
dc.contributor.funder | Ministerio de Economía y Competitividad (España) | |
dc.contributor.funder | Instituto de Salud Carlos III | |
dc.contributor.funder | Red de Investigación Cooperativa en Investigación en Sida (España) | |
dc.identifier.e-issn | 1744-8336 | es_ES |
dc.relation.publisherversion | https://doi.org/10.1080/14787210.2017.1308823 | es_ES |
dc.identifier.journal | Expert review of anti-infective therapy | es_ES |
dc.repisalud.centro | ISCIII::Centro Nacional de Microbiología | es_ES |
dc.repisalud.institucion | ISCIII | es_ES |
dc.relation.projectID | info:eu-repo/grantAgreement/ES/SAF2013-44677-R | es_ES |
dc.relation.projectID | info:eu-repo/grantAgreement/ES/SAF2016-78480-R | es_ES |
dc.relation.projectID | info:eu-repo/grantAgreement/ES/PI16CIII/00034 | es_ES |
dc.relation.projectID | info:eu-repo/grantAgreement/ES/RD16CIII/0002/0001 | es_ES |
dc.rights.accessRights | open access | es_ES |